7 May 2025 

GenIP Plc

("GenIP" or the "Company")

GenIP to attend 2025 AUTM Canadian Region Meeting

GenIP Plc, a company providing GenAI analytic services to help organisations assess and commercialise new discoveries, is pleased to announce its participation in the 2025 AUTM Canadian Region Meeting, taking place from May 6-8, 2025, in Montreal, Quebec.

This marks GenIP's first formal introduction to the Canadian innovation and technology transfer community, offering a valuable opportunity to engage with potential clients, including university Technology Transfer Offices, public research institutions, and innovation-driven organisations.

The event will gather over 100 technology transfer professionals to explore topics such as express licensing, startup funding models, and strategies for moving innovations from lab to market.

After successfully securing new clients at similar events, GenIP looks forward to contributing to the Canadian innovation conversation and showcasing how its AI-powered analytics can support faster, evidence-based commercialisation decisions.

Melissa Cruz, CEO of GenIP, commented:

"We're excited to introduce GenIP's services to the Canadian tech transfer community. Our GenAI-driven evaluations are designed to help institutions unlock the commercial potential of their innovations faster and more efficiently. The AUTM meeting is an ideal platform to engage with forward-thinking organisations who share our vision for accelerating innovation."

For further information regarding GenIP, please visit www.genip.ai, or contact:

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.